Ticker
ABUSCompany Name
ARBUTUS BIOPHARMA CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) |
---|---|
6/30/2025 | $ -54.14M |
3/31/2025 | $ -76.45M |
12/31/2024 | $ -69.78M |
9/30/2024 | $ -76.55M |
6/30/2024 | $ -76.92M |
3/31/2024 | $ -74.08M |
12/31/2023 | $ -72.39M |
9/30/2023 | $ -74.75M |
6/30/2023 | $ -71.83M |
3/31/2023 | $ -68.61M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Minimum
Jun 30, 2024
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.29K |
---|---|
min | $ -402.08M |
max | $ 442.4M |
average | $ 28.62M |
median | $ 897.02K |
std | $ 130.62M |